Cholesterol

Increased physical activity was significantly associated with reduced likelihood of adverse heart events and mortality, according to findings presented at the European Society of Cardiology preventive cardiology meeting.

The FDA recently approved a therapy that combines rosuvastatin, a statin for LDL reduction, and ezetimibe, a cholesterol absorption inhibitor, for adults with primary nonfamilial hyperlipidemia or homozygous familial hypercholesterolemia.

Cholesterol increases significantly in infants during the first year of life; however, high-sugar formula feeding vs. breastfeeding may be associated with dyslipidemia later in life, researchers wrote in the European Heart Journal.

The FDA has approved the expanded indication for alirocumab injection for adult patients with homozygous familial hypercholesterolemia, or HoFH, as an add-on therapy to other treatments for HoFH.

Althera announced the FDA approved its rosuvastatin/ezetimibe tablets as an adjunct to diet for treatment of elevated LDL in adults with primary nonfamilial hyperlipidemia or homozygous familial hypercholesterolemia.

Significant therapeutic advancements have been achieved in the management of dyslipidemia. The ability to decrease LDL to previously unattainable levels, owing largely to the development of PCSK9 monoclonal antibodies, has illuminated two important lessons.

Lifestyle intervention to improve cardiometabolic risk factors in patients with obesity.

Cholesterol testing dropped during the COVID-19 pandemic, raising concerns about providing patients with proper preventive care, according to a study published in the American Journal of Preventive Cardiology.

Whole egg and cholesterol intake was associated with CVD, cancer and all-cause mortality, data from a cohort of more than a half million people showed.

A 24-month lifestyle intervention provided in the primary care setting by health coaches improved cardiometabolic risk factors among patients with obesity compared with usual care alone, according to data published in Circulation.